Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hertz

Showing results (361-370 of 368) with videos related to

Pageof 37
Sort By:
You have reached the last page of results.This site can display upto 368 results.
British Journal of Clinical Pharmacology|April 25, 2015
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and allelesDaniel L Hertz, Anna C Snavely, Howard L McLeod, et al.
The Oncologist|May 27, 2016
Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing ToxicityDaniel L Hertz, Allison Deal, Joseph G Ibrahim, et al.
British Journal of Cancer|October 7, 2021
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patientsJulia C F Quintanilha, Jin Wang, Alexander B Sibley, et al.
Clinical Pharmacology and Therapeutics|March 18, 2024
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM CohortAnna M Mc Laughlin, Thomas Helland, Fenja Klima, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 25, 2016
[Neonatal arterial ischemic stroke: Review of the current guidelines]E Saliba, T Debillon, , et al.
Eclinicalmedicine|September 23, 2024
Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care-an international Delphi studyRaymond Javan Chan, Reegan Knowles, Fredrick D Ashbury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2016
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced NeuropathyDaniel L Hertz, Kouros Owzar, Sherrie Lessans, et al.
G3 (Bethesda, Md.)|July 2, 2017
Retrotransposons Are the Major Contributors to the Expansion of the <i>Drosophila ananassae</i> Muller F ElementWilson Leung, Christopher D Shaffer, Elizabeth J Chen, et al.
Pageof 37

Showing results (361-370 of 368) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 368 results.
British Journal of Clinical Pharmacology|April 25, 2015
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and allelesDaniel L Hertz, Anna C Snavely, Howard L McLeod, et al.
The Oncologist|May 27, 2016
Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing ToxicityDaniel L Hertz, Allison Deal, Joseph G Ibrahim, et al.
British Journal of Cancer|October 7, 2021
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patientsJulia C F Quintanilha, Jin Wang, Alexander B Sibley, et al.
Clinical Pharmacology and Therapeutics|March 18, 2024
Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM CohortAnna M Mc Laughlin, Thomas Helland, Fenja Klima, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|December 25, 2016
[Neonatal arterial ischemic stroke: Review of the current guidelines]E Saliba, T Debillon, , et al.
Eclinicalmedicine|September 23, 2024
Supportive care 2030 movement: towards unifying ambitions for global excellence in supportive cancer care-an international Delphi studyRaymond Javan Chan, Reegan Knowles, Fredrick D Ashbury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2016
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced NeuropathyDaniel L Hertz, Kouros Owzar, Sherrie Lessans, et al.
G3 (Bethesda, Md.)|July 2, 2017
Retrotransposons Are the Major Contributors to the Expansion of the <i>Drosophila ananassae</i> Muller F ElementWilson Leung, Christopher D Shaffer, Elizabeth J Chen, et al.
Pageof 37